# US 2021/0171930 A1 · Tripterygium wilfordii cryptomeridiol synthase, coding gene thereof and recombinant yeast containing coding gene

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171930 A1
- Document ID: US20210171930A1
- Status: Published application
- Kind: A1
- Application number: 16/968,338
- Filed: 2019-01-30
- Published: 2021-06-10
- Earliest claimed: 2018-02-09
- Assignees: Capital Medical University
- Applicants: Capital Medical University
- Inventors: Wei GAO; Luqi HUANG; Yuru TONG; Tianyuan HU
- Web page: https://patentgrep.com/patent/US20210171930A1

## CPC

- C12N 9/88: Lyases (4.)
- C12Y 402/03: acting on phosphates (4.2.3)
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 15/81: for yeasts
- C12P 5/007: {containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00)}
- C12P 7/02: containing a hydroxy group
- C12Y 101/01034: Hydroxymethylglutaryl-CoA reductase (NADPH) (1.1.1.34)
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Provided are a Cryptomeridiol synthase and a coding gene thereof. Also provided are a Cryptomeridiol synthase and a coding gene, a engineered yeast containing the Cryptomeridiol coding gene, and a use of same in plant breeding and biosynthesis. The cDNA full-length sequence of the Cryptomeridiol synthase gene in Tripterygium wilfordii is obtained by means of polymerase chain reaction cloning. Then, by means of synthetic biology, the engineered yeast containing the Cryptomeridiol synthase gene is constructed to realize the production of Cryptomeridiol in the yeast.

## Claims

### Claim 1

Cryptomeridiol synthase, with amino acid sequence as SEQ ID NO:2.

### Claim 2 (depends on 1)

Gene encoding the synthase of claim 1, wherein the gene is at least one of following:
(1) nucleotide molecule shown in SEQ ID NO:1;
(2) nucleotide sequence resulted from the nucleotide molecule shown in SEQ ID NO:1 being substituted, deleted or added with one or more nucleotide, with expressing same function of protein;
(3) nucleotide sequence hybridized with the nucleotide molecules shown in SEQ ID NO:1 under stringent conditions, in which the stringent conditions are that hybridizing in 0.1×SSPE solution containing 0.1% of SDS or 0.1×SSC solution containing 0.1% of SDS.

### Claim 3 (depends on 2)

A recombinant expression vector, comprising a promoter, the gene of claim 2 and a transcription terminator.

### Claim 4 (depends on 3)

The expression vector of claim 3, which is obtained from splicing the promoter, the gene encoding the cryptomeridiol synthase, the terminator, and episomal vector by using a method of yeast homologous recombination, in which the episomal vector is a yeast expression vector, including one of pYX212, pYES2.0, pRS425, pRS426 and p424.

### Claim 5 (depends on 3)

The expression vector of claim 3, wherein the vector is any one of the following:
(1) recombinant expression vector pYX212-TwCS, which contains promoter TPIp, cryptomeridiol synthase expression gene TwCS and terminator pYX12t;
(2) recombinant expression vector pYX212-ERG20+TwCS, which contains promoter TPIp, EGR20 gene sequence, yeast terminator FBA1t, yeast promoter TEF1p, cryptomeridiol synthase expression gene TwCS and terminator pYX12t;
(3) recombinant expression vector pYX212-IDI+TwCS, which contains promoter TPIp, IDI gene, yeast terminator FBA1t, yeast promoter TEF1p, cryptomeridiol synthase expression gene TwCS and terminator pYX121;
(4) recombinant expression vector pYX212-(IDI-EGR20)+TwCS, which contains promoter TPIp, IDI gene, fusion protein linker peptide, EGR20 gene, yeast terminator FBA1t, yeast promoter TEF1p, cryptomeridiol synthase expression gene TwCS and terminator pYX12t;
(5) recombinant expression vector pYX212-(EGR20-IDI)+TwCS, which contains promoter TPIp, EGR20 gene sequence, fusion protein linker peptide, IDI gene, yeast terminator FBA1t, yeast promoter TEF1p, cryptomeridiol synthase expression gene TwCS and terminator pYX12t;
wherein the fusion protein is any one of GGGS (SEQ ID NO: 44), GSG, GSGGGGS (SEO ID NO: 45) GSGEAAAK (SEQ ID NO: 46) GSGEAAAKEAAAK (SEQ ID NO: 47) and GSGMGSSSN (SEQ ID NO: 48), wherein the GGGS (SEQ ID NO: 44) is with coding gene of ggtggtggttct (SEO ID NO: 49).

### Claim 6 (depends on 3)

Engineered bacteria producing cryptomeridiol, which comprises the recombinant expression vector of claim 3.

### Claim 7 (depends on 6)

The engineered bacteria of claim 6, wherein the engineered bacteria are selected from yeast cells or plant cells.

### Claim 8 (depends on 7)

The engineered bacteria of claim 7, wherein the engineered bacteria are selected from yeast cells.

### Claim 9 (depends on 8)

The engineered bacteria of claim 8, wherein at least one of erg9 and rox1 genes are knocked out from the engineered bacteria.

### Claim 10 (depends on 6)

The engineered bacteria of claim 6, which is constructed by a method comprising:
(1) transforming recombinant expression vector pYX212-TwCS into yeast BY4741 strain to obtain engineering strain TE1; or
(2) transforming recombinant expression vector pYX212-ERG20+TwCS into yeast BY4741 strain to obtain engineered strain TE2; or
(3) transforming recombinant expression vector pYX212-IDI+TwCS into yeast BY4741 strain to obtain engineered strain TE3; or
(4) transforming recombinant expression vector pYX212-(IDI-EGR20)+TwCS into yeast BY4741 strain to obtain engineered strain TE4; or
(5) transforming recombinant expression vector pYX212-(EGR20-IDI)+TCS into yeast BY4741 strain to obtain engineered strain TE5; or
(6) transforming recombinant expression vector pYX212-(EGR20-IDI)+TwCS and the recombinant expression vector p424-tHMG1 into the yeast BY4741 strain to obtain engineered strain TE6; or
(7) transforming recombinant expression vector pYX212-IDI+TwCS and the recombinant expression vector p424-tHMG1 into the yeast BY4741 strain to obtain engineered strain TE7;
wherein the recombinant expression vector p424-tHMG1 includes yeast promoter TDH3p, truncated HMG-CoA reductase gene tHMG1, yeast terminator TDH31.

### Claim 11 (depends on 9)

The engineered bacteria of claim 9, which is constructed by a method comprising:
(1) construction of mutant strains, that is,
knocking out the erg9 gene in the BY4741 yeast strain, to obtain mutant strain BY4741erg9::Δ-200-176; or
knocking out the erg9 gene and the rox1 gene in the BY4741 yeast strain, to obtain mutant strain BY4741 erg9::Δ-200-176 rox1::mut;
(2) transforming recombinant expression vectors pYX212-IDI+TwCS and p424-tHMG1 into the mutant strain BY4741erg9::Δ-200-176, to obtain yeast engineering strain TE8; or
transforming recombinant expression vectors pYX212-IDI+TwCS and p424-tHMG1 into the mutant yeast strain BY4741 erg9::Δ-200-176 rox1::mut to obtain the yeast engineering strain TE9.

### Claim 12 (depends on 11)

The engineered bacteria of claim 11, wherein a method for constructing the mutant strain is a modification by CRISP/Cas9 gene editing technology.

### Claim 13 (depends on 12)

The engineered bacteria of claim 12, wherein in the CRISP/Cas9 gene editing technology, an expression vector containing Cas9 is a p414-TEF1p-Cas9-CYC1t vector, and TRP screening marker in the p414-TEF1p-Cas9-CYC1t vector is replaced with LEU screening marker.

### Claim 14

(canceled)

### Claim 15

(canceled)
